Last edition
News about "ANI Pharmaceuticals"
ANI Pharmaceuticals Introduces Prucalopride Tablets after FDA Approval
ANI’s Prucalopride Tablets is the generic version of the reference listed drug (RLD) Motegrity.
ANI Pharmaceuticals | 03/01/2025 | By Aishwarya | 376
ANI Pharmaceuticals to Acquire Alimera to Expand Rare Disease
ANI Pharmaceuticals, Inc. has announced that ANI will acquire Alimera for USD 5.50 per share in cash at closing and one non-tradable contingent value right (CVR) representing the right to receive up to USD 0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027.
ANI Pharmaceuticals | 25/06/2024 | By Aishwarya | 599
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy